XML 34 R23.htm IDEA: XBRL DOCUMENT v3.20.2
Net loss per share (Tables)
9 Months Ended
Sep. 30, 2020
Earnings Per Share [Abstract]  
Schedule of Calculation of Basic and Diluted Earnings Per Share

 

 

 

The following table presents the calculation of basic and diluted earnings per share (in thousands, except per-share amounts):

 

 

Three Months Ended

September 30,

 

 

Nine Months Ended

September 30,

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) - basic

$

(8,545

)

 

$

889

 

 

$

(21,787

)

 

$

(16,149

)

Less: noncash income from change in fair value of warrants

 

 

 

 

7,090

 

 

 

 

 

 

906

 

Net loss - diluted

$

(8,545

)

 

$

(6,201

)

 

$

(21,787

)

 

$

(17,055

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic weighted-average common shares outstanding

 

79,583,254

 

 

 

31,793,292

 

 

 

56,916,137

 

 

 

31,775,590

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Effect of dilutive securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options to purchase common stock

 

 

 

 

260,882

 

 

 

 

 

 

236,395

 

Warrants

 

 

 

 

389,473

 

 

 

 

 

 

223,543

 

Diluted weighted-average common shares outstanding

 

79,583,254

 

 

 

32,443,647

 

 

 

56,916,137

 

 

 

32,235,528

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per common share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

$

(0.11

)

 

$

0.03

 

 

$

(0.38

)

 

$

(0.51

)

Diluted

$

(0.11

)

 

$

(0.19

)

 

$

(0.38

)

 

$

(0.53

)

Schedule of Potentially Dilutive Securities Outstanding Excluded from Computations of Diluted Weighted-Average Shares Outstanding

The following potentially dilutive securities outstanding have been excluded from the computations of diluted weighted-average shares outstanding for the periods presented because such securities have an antidilutive impact, either due to the losses reported or because the exercise price was greater than the average market price of the shares of common stock during the period.

 

 

 

Three Months Ended

September 30,

 

 

Nine Months Ended

September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Warrants issued to 2010/2012 convertible note

   holders to purchase common stock

 

 

102,070

 

 

 

102,070

 

 

 

102,070

 

 

 

102,070

 

Options to purchase common stock

 

 

2,513,739

 

 

 

1,875,442

 

 

 

2,513,739

 

 

 

1,899,930

 

Outstanding restricted stock units

 

 

581,000

 

 

 

 

 

 

581,000

 

 

 

 

Warrants issued to underwriter to purchase common stock

 

 

16,500

 

 

 

16,500

 

 

 

16,500

 

 

 

16,500

 

Series A warrants to purchase common stock

 

 

 

 

 

485,121

 

 

 

 

 

 

485,121

 

Series C warrants to purchase common stock

 

 

 

 

 

118,083

 

 

 

 

 

 

118,083

 

Series D warrants to purchase common stock

 

 

540,540

 

 

 

540,540

 

 

 

540,540

 

 

 

540,540

 

2017 PIPE warrants

 

 

6,024,425

 

 

 

5,665,548

 

 

 

6,024,425

 

 

 

5,818,443

 

2018 PIPE warrants

 

 

513,617

 

 

 

483,021

 

 

 

513,617

 

 

 

496,056

 

Total

 

 

10,291,891

 

 

 

9,286,325

 

 

 

10,291,891

 

 

 

9,476,743